Matthew Wein

MGX

Matthew Wein serves as officer: See Remarks at Metagenomi, Inc. Common Stock (MGX). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

6 trades

$4.3K

Net Position

Net Seller

$4.3K

Companies Traded

MGX

Active Period

Mar 2025 – Jun 2026

6 total trades

Most Recent

Sell MGX

Jun 10, 2026 · $724.84

Matthew Wein's Insider Trading at Metagenomi, Inc. Common Stock (MGX)

Buys

0 · $0.00

Sells

6 · $4.3K

Total Shares Bought

Total Shares Sold

2,567

MGX Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Jun 10, 2026	Sell	558	$1.30	$724.84	126,491
Mar 9, 2026	Sell	482	$1.60	$771.20	114,549
Dec 5, 2025	Sell	199	$1.77	$352.61	0
Sep 5, 2025	Sell	199	$1.81	$360.19	0
Jun 6, 2025	Sell	199	$1.75	$348.25	0
Mar 5, 2025	Sell	930	$1.87	$1.7K	0

Related Insiders

Jian Irish

director, officer: See Remarks

MGXSell · Jun 10, 2026

Pamela Wapnick

officer: Chief Financial Officer

MGXSell · Jun 10, 2026

Brian C. Thomas

Director

MGXSell · Dec 5, 2025

Explore More Insider Trading Data

MGX Insider Trading Activity

View all insider trades at Metagenomi, Inc. Common Stock

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity